HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wahba, A. Articles by Birnbaum, D. E. Search for Related Content PubMed PubMed Citation Articles by Wahba, A. Articles by Birnbaum, D. E.

European Journal of Cardio-Thoracic Surgery, Vol 10, 768-773, Copyright © 1996 by European Association for Cardio-thoracic Surgery

ARTICLES

Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens

A Wahba, G Black, M Koksch, G Rothe, J Preuner, G Schmitz and DE Birnbaum
Department of Cardiae, Thoracic and Vascular Surgery, Klinikum Regensburg, University of Regensburg, Germany.

OBJECTIVE: In a prospective study surface antigens associated with platelet activation, aggregation, and adhesion and the platelet volume were measured to investigate the mechanism of the platelet function defect of cardiopulmonary bypass (CPB). METHODS: Blood samples were obtained during cardiac surgery before and after heparinization, as well as during and following extracorporeal circulation. The expression of the platelet surface glycoproteins (GP) IIb-IIIa, Ib, 53, and the granule membrane protein (GMP) 140 were measured using flow cytometry in platelet-rich plasma (PRP) before and after in vitro stimulation with adenosine diphosphate. A full blood count including mean platelet volume (MPV) was taken. RESULTS: Heparinization resulted in a significant increase of GP 53 and GMP 140 and a significant decrease of GP Ib expression. During and following CPB, GP IIb-IIIa and Ib were significantly decreased. Similarly, the expression of the activation markers was reduced significantly. The mean platelet volume decreased significantly from 8.6 +/- 0.7 fl at baseline to 7.9 +/- 0.8 fl at the end of the study period. CONCLUSION: Our data suggest that heparinization induces platelet activation. We assume that a loss of larger and more activated platelets from the circulation contributes substantially to the platelet function defect of CPB.

This article has been cited by other articles:

				R. Gerrah, A. Brill, S. Tshori, A. Lubetsky, G. Merin, and D. Varon Using Cone and Plate(let) Analyzer to Predict Bleeding in Cardiac Surgery. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 310 - 315. [Abstract] [Full Text] [PDF]

				H. Pleym, V. Videm, A. Wahba, A. Asberg, T. Amundsen, L. Bjella, O. Dale, and R. Stenseth Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 933 - 940. [Abstract] [Full Text] [PDF]

				H. Pleym, A. Wahba, V. Videm, A. Asberg, S. Lydersen, L. Bjella, O. Dale, and R. Stenseth Increased fibrinolysis and platelet activation in elderly patients undergoing coronary bypass surgery. Anesth. Analg., March 1, 2006; 102(3): 660 - 667. [Abstract] [Full Text] [PDF]

				G. Shanmugam Tirofiban and emergency coronary surgery Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 546 - 550. [Abstract] [Full Text] [PDF]

				A. Wahba and V. Videm Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1046 - 1050. [Abstract] [Full Text] [PDF]

				E. W. Muriithi, P. R. Belcher, and V. C. Menys Preoperative platelet inhibition and bleeding after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 739 - 739. [Full Text] [PDF]

				K. Kottke-Marchant and S. Sapatnekar Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206. [Abstract] [PDF]

				E. W. Muriithi and P. R. Belcher Heparin and platelet function Ann. Thorac. Surg., July 1, 2001; 72(1): 320 - 321. [Full Text] [PDF]

				E. W. Muriithi, P. R. Belcher, J. N. Rao, M. A. Chaudhry, D. Nicol, and D. J. Wheatley The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 538 - 543. [Abstract] [Full Text] [PDF]

				S. A. Kozek-Langenecker, S. F. Mohammad, T. Masaki, C. Kamerath, and A. K. Cheung The Effects of Heparin, Protamine, and Heparinase 1 on Platelets in vitro Using Whole Blood Flow Cytometry Anesth. Analg., April 1, 2000; 90(4): 808 - 812. [Abstract] [Full Text] [PDF]

				W. Reents, J. Babin-Ebell, M. R. Misoph, A. Schwarzkopf, and O. Elert Influence of different autotransfusion devices on the quality of salvaged blood Ann. Thorac. Surg., July 1, 1999; 68(1): 58 - 62. [Abstract] [Full Text] [PDF]

				A. Gries, C. Bode, S. Gross, K. Peter, H. Bohrer, and E. Martin The Effect of Intravenously Administered Magnesium on Platelet Function in Patients After Cardiac Surgery Anesth. Analg., June 1, 1999; 88(6): 1213 - 1213. [Abstract] [Full Text] [PDF]

				J. A. Hyde, J. A Chinn, and T. R Graham Platelets and cardiopulmonary bypass Perfusion, December 1, 1998; 13(6): 389 - 407. [PDF]

				A. Weerasinghe and K. M. Taylor The platelet in cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1998; 66(6): 2145 - 2152. [Abstract] [Full Text] [PDF]